NOVAMOXIN TABLET (CHEWABLE)

Pajjiż: Kanada

Lingwa: Ingliż

Sors: Health Canada

Ingredjent attiv:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE)

Disponibbli minn:

TEVA CANADA LIMITED

Kodiċi ATC:

J01CA04

INN (Isem Internazzjonali):

AMOXICILLIN

Dożaġġ:

125MG

Għamla farmaċewtika:

TABLET (CHEWABLE)

Kompożizzjoni:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 125MG

Rotta amministrattiva:

ORAL

Unitajiet fil-pakkett:

100

Tip ta 'preskrizzjoni:

Prescription

Żona terapewtika:

AMINOPENICILLINS

Sommarju tal-prodott:

Active ingredient group (AIG) number: 0131314009; AHFS:

L-istatus ta 'awtorizzazzjoni:

CANCELLED POST MARKET

Data ta 'l-awtorizzazzjoni:

2021-07-29

Karatteristiċi tal-prodott

1
PRODUCT MONOGRAPH
PR NOVAMOXIN
AMOXICILLIN CAPSULES, USP
250 MG AND 500 MG AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AMOXICILLIN CHEWABLE TABLETS, USP
125 MG AND 250 MG AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AMOXICILLIN GRANULES FOR ORAL SUSPENSION, USP
125 MG/5 ML AND 250 MG/5 ML AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AFTER RECONSTITUTION
AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL
SUSPENSION, TEVA STANDARD
125 MG/5 ML AND 250 MG/5 ML AMOXICILLIN (AS AMOXICILLIN TRIHYDRATE)
AFTER RECONSTITUTION
Antibiotic
Teva Canada Limited
Date of Revision:
30 Novopharm Court
March 20, 2020
Toronto, Ontario
Canada M1B 2K9
www.tevacanada.com
Control # 233622
2
NAME OF DRUG
NOVAMOXIN
(AMOXICILLIN TRIHYDRATE)
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION AND CLINICAL PHARMACOLOGY
Novamoxin (amoxicillin) exerts its bactericidal action by interfering
with bacterial cell
wall synthesis.
COMPARATIVE BIOAVAILABILITY STUDIES - TABLETS
A comparative two-way, single-dose bioavailability study was carried
out in sixteen
healthy, male volunteers on two 250 mg amoxicillin tablet products,
Novamoxin 250 mg
and Amoxil 250 mg chewable tablets. The pharmacokinetic data of
fifteen subjects
calculated for the Novamoxin and Amoxil chewable tablet formulations
is tabulated
below:
AMOXICILLIN TRIHYDRATE CHEWABLE TABLETS 250 MG
FROM MEASURED DATA
Geometric Mean
Arithmetic Mean (C.V.%)
PARAMETER
TEST
*
REFERENCE
†
% RATIO OF
GEOMETRIC
MEANS
95%
CONFIDENCE
INTERVAL
AUC
T
(µg*h/mL)
20.3
20.4 (10)
20.5
20.7 (16)
99
91.8 – 108.4
AUC
I
(µg• h/mL)
20.5
20.5 (10)
20.5
20.8 (16)
100
91.8 – 108.5
C
max
(µg/mL)
7.4
7.5 (13)
7.7
8.0 (26)
96
84.8 – 109.1
T
max
§
(h)
1.37 (0.40)
1.43 (0.46)
-
T
1/2
§
(h)
0.95 (0.11)
0.92 (0.09)
-
* Novamoxin
250 mg Chewable Tablet (Novopharm Ltd.).
†
Amoxil
®
250 mg Chewable Tablet (purchased in Canada).
§
Expressed as the arithmetic mean (standard deviation) only.
3
INDICATIONS AND CLINICAL USE
Novamoxin (amoxicillin) may be indicated in the treatment of
infections due to
susceptible strains of the following m